| BCBS Minnesota | Gender Affirming Procedures | 2025-10-06 |
| BCBS Minnesota | Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma | 2025-10-06 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Transplant Rejection Testing | 2025-10-06 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Crizanlizumab-tmca (Adakveo) | 2025-10-06 |
| BCBS Highmark Penn Medicare Advantage | Naxitamab (Danyelza) | 2025-10-06 |
| BCBS Highmark NY and West NY | Transplant Rejection Testing | 2025-10-06 |
| BCBS Highmark NY and West NY | Luspatercept (Reblozyl) | 2025-10-06 |
| BCBS Highmark NY and West NY | Octreotide acetate (Sandostatin, Sandostatin LAR) and Lanreotide (Somatuline Depot) | 2025-10-06 |
| BCBS Highmark NY and West NY | Naxitamab (Danyelza) | 2025-10-06 |
| BCBS Highmark NY and West NY | Crizanlizumab-tmca (Adakveo) | 2025-10-06 |